A new report from the Centers for Disease Control and Prevention (CDC) identifies 10 evidence‐based opioid overdose prevention strategies that the text says "states and municipalities can take today to prevent new overdoses tomorrow." In including on the list items such as Good Samaritan ...
In addition, they may not as readily engage with harm reduction or treatment services, which would otherwise have mitigated the risks that they are exposed to [23]. Third, even if there was convincing evidence that the punishment of people who use drugs deterred wider use and did not have ...
The partial reduction in withdrawal achieved by NRT could well be the result of the inadequacy of the placebo controls used in the majority, if not all, of these studies. Several laboratory studies using the balanced placebo design demonstrate that smokers' responses to nicotine are determined to...
Scorecard Chemical Profile:Leuprolide = "Reproductive & Developmental Toxicant".Goserelin alsois recognized as a "Reproductive & Developmental Toxicant". CDC/NIOSH "List of Antineoplastic Hazardous Drugs" ...Leuprolide = "Hazardous Drug". Leuprolide (Lupron) on all NIOSH 'Antineoplastic Hazardous Drug L...
356. https://www.cdc.gov/nchs/data/databriefs/db356-h.pdf. Last accessed Oct 30, 2020. Heimer R, McNeil R, Vlahov D. A community responds to the COVID-19 pandemic: a case study in protecting the health and human rights of people who use drugs. J Urban Health. 2020;97(4):448...
Last week, the federal government held a landmark "summit" on harm reduction. By invitation only, the meeting was sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Centers for Disease Control and Prevention (CDC) and the Office of National Drug Control ...
When questions arose about health risks of tobacco, they focused on two key themes: 1) how bad is the problem (i.e., absolute risk) and 2) what can be done to reduce the risk without cessation (i.e., prospects for harm reduction). Using the United States since 1964 as an example,...
The introduction of a second-tier test to detect the level of methylmalonic acid (MMA) from the initial bloodspot has vastly improved the screening test for propionic aciduria and methylmalonic aciduria, resulting in the reduction of the unnecessary recalls associated with this biomarker [12,13]. ...